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The trace amines (TAs), tryptamine, tyramine, and β-phenylethylamine, are synthesized
from precursor amino acids via aromatic-L-amino acid decarboxylase (AADC). We explored
their role in the neuromodulation of neonatal rat spinal cord motor circuits. We first
showed that the spinal cord contains the substrates for TA biosynthesis (AADC) and for
receptor-mediated actions via trace amine-associated receptors (TAARs) 1 and 4. We next
examined the actions of the TAs on motor activity using the in vitro isolated neonatal
rat spinal cord. Tyramine and tryptamine most consistently increased motor activity
with prominent direct actions on motoneurons. In the presence of N-methyl-D-aspartate,
all applied TAs supported expression of a locomotor-like activity (LLA) that was
indistinguishable from that ordinarily observed with serotonin, suggesting that the TAs
act on common central pattern generating neurons. The TAs also generated distinctive
complex rhythms characterized by episodic bouts of LLA. TA actions on locomotor circuits
did not require interaction with descending monoaminergic projections since evoked
LLA was maintained following block of all Na+-dependent monoamine transporters or
the vesicular monoamine transporter. Instead, TA (tryptamine and tyramine) actions
depended on intracellular uptake via pentamidine-sensitive Na+-independent membrane
transporters. Requirement for intracellular transport is consistent with the TAs having
much slower LLA onset than serotonin and for activation of intracellular TAARs. To test
for endogenous actions following biosynthesis, we increased intracellular amino acid
levels with cycloheximide. LLA emerged and included distinctive TA-like episodic bouts.
In summary, we provided anatomical and functional evidence of the TAs as an intrinsic
spinal monoaminergic modulatory system capable of promoting recruitment of locomotor
circuits independent of the descending monoamines. These actions support their known
sympathomimetic function.
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INTRODUCTION
The classical monoamine neuromodulatory transmitters,
dopamine (DA), noradrenaline (NA), and serotonin (5-HT), play
an important role in modulating spinal cord sensory, autonomic
andmotor function (Jacobs and Fornal, 1993; Rekling et al., 2000;
Schmidt and Jordan, 2000; Hochman et al., 2001; Millan, 2002;
Clarac et al., 2004; Zimmerman et al., 2012; Garcia-Ramirez et al.,
2014). Their actions are thought to occur largely via descending
monoaminergic neurons that project to the spinal cord (Gerin
et al., 1995).
Another group of endogenous monoamines called the
trace amines (TAs), include tryptamine, tyramine, and β-
phenylethylamine (PEA). The TAs have structural, metabolic,
physiologic, and pharmacologic similarities to the classical
monoamine transmitters and are synthesized from the same
precursor amino acids (Saavedra, 1989). Unlike the classical
monoamines, aromatic-L-amino acid decarboxylase (AADC; also
called dopa decarboxylase) is the only enzyme required to pro-
duce them. Conversion from the TAs to the monoamines does
not appear to occur (Berry, 2007).
The TAs have a heterogeneous central nervous system (CNS)
distribution with concentrations ranging from 0.1 to 13 ng/g
(Durden et al., 1973; Philips et al., 1974a,b, 1975; Boulton, 1976,
1978; Juorio, 1988; Nguyen and Juorio, 1989; Boulton et al.,
1990). There are mixed reports on whether the concentrations are
higher in spinal cord or brain (Spector et al., 1963; Boulton et al.,
1977; Juorio, 1979, 1980; Karoum et al., 1979).While often viewed
as metabolic by-products (Boulton, 1976; Berry, 2004), the TAs
are clearly neuroactive. For example, in spinal cord PEA enhanced
while tyramine depressed monosynaptic reflexes (Kitazawa et al.,
1985; Ono et al., 1991). Tyramine also depressed flexion and
crossed-extension reflexes (Bowman et al., 1964) consistent with
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reported antinociceptive actions (Reddy et al., 1980). Tyramine
also directly depolarized motoneurons with an EC50 comparable
to DA (∼50µM) (Kitazawa et al., 1985).
The recent discovery of trace amine-associated receptors
(TAARs) establishes a mechanism by which TAs can produce
effects of their own (Borowsky et al., 2001; Bunzow et al., 2001).
Tyramine and PEA activate TAAR1, while PEA and tryptamine
activate TAAR4 (Borowsky et al., 2001). Observations using selec-
tive TAAR1 agonists and antagonists and TAAR1 knockout mice
demonstrate a clear role for TA actions on CNS TAAR1 recep-
tors. TAAR1 activity appears to depress monoamine transport
and limit dopaminergic and serotonergic neuronal firing rates
via interactions with presynaptic D2 and 5-HT1A autoreceptors,
respectively (Wolinsky et al., 2007; Lindemann et al., 2008; Xie
and Miller, 2008; Xie et al., 2008; Bradaia et al., 2009; Revel et al.,
2011; Leo et al., 2014). This supports a large classical literature on
the role of TAs as endogenous neuromodulators of monoamin-
ergic excitability and neurotransmission (Boulton, 1991; Berry,
2004).
TA-induced modulatory actions in the CNS have yet to be
linked with specific trace aminergic neuronal systems. Candidate
neurons include 16 anatomically segregated collections of D cells
(Jaeger et al., 1984). D cells contain the essential synthesis enzyme
AADC but no other monoamine synthesis enzymes, and can only
synthesize the TAs from their precursor amino acids (Jaeger et al.,
1983, 1984; Nagatsu et al., 1988). D1 cells associate with the
lumen of the spinal cord central canal (Jaeger et al., 1983). While
the function of these neurons is unknown, a morphologically
similar population activates locomotor circuits in larval zebrafish
(Wyart et al., 2009).
As TAAR1 mRNA is found in the spinal cord (Borowsky
et al., 2001), we hypothesize that the TAs and their receptors
represent an intrinsic neuromodulatory system. Here, we char-
acterize spinal expression patterns for AADC, tyramine, TAAR1
and TAAR4, then make use of an isolated neonatal rat spinal cord
preparation to examine the role of applied TAs on spinal motor
circuits (Kiehn, 2006). Overall we show that the TAs can activate
complex rhythmic motor behaviors, including locomotor-like
activity (LLA), independent of classical monoaminergic mecha-
nisms. Some of these results have been presented in abstract form
(Gieseker et al., 2004; Gozal et al., 2006, 2007).
MATERIALS AND METHODS
All experimental procedures complied with the NIH guidelines
for animal care and the Emory Institutional Animal Care and
Use Committee. Sprague-Dawley rats aged post-natal day (P) 0–5,
P14, and adult were used.
TAAR PCR
Total RNA was extracted from male and female rat whole spinal
cords (P2) using QIAGEN RNeasy Mini Kit (Cat No: 74104). We
performed on-column DNase digestion using the same QIAGEN
kit. Total RNA was quantified by NanoDrop 2000 (Thermo
Scientific). DNase-treated total RNA (1µg) was retrotranscribed
using the iScript cDNA synthesis kit according to the instructions
of the manufacturer (Bio-Rad Laboratories, Hercules, CA, USA).
Platinum PCR SuperMix was used for PCR reactions following
the instructions of the manufacturer (Invitrogen, Cat No: 11306-
016). PCR was conducted with the following cycling program:
2min at 95◦C of initial denaturation, followed by 37 cycles of
denaturation at 95◦C for 30 s, annealing at 60◦C for all TAAR
primers for 30 s (except TAAR7 and TAAR9 which were at 55◦C),
and extension at 72◦C for 30 s. PCR products were size-separated
by electrophoresis in ethidium bromide-stained 2% agarose gels
with bands visualized by ultraviolet transillumination.
Primer sequence information for TAARs 1–6, 8a, and 9 were
obtained from Chiellini et al. (2007). We also used one of introns
of Rattus norvegicus strain BN/SsNHsdMCW chromosome 1
(RGSC_v3.4) as a negative control to make sure that the total
RNA from the whole spinal cord was not contaminated by the
genomic DNA. Primer sequences for GAPDH and RGSC_v3.4
are: GAPDH (NM017008): forward primer, 5′-GCAACTCC
CATTCTTCCACCTTTGA-3′; reverse primer, 5′-TTGGAGGC
CATGTAGGCCATGA-3′ (139 bp). RGSC_v3.4 intron (NC_0051
00.2): forward primer, 5′-AGAGTGGTCTGTTGCAAGTGGTCT-
3′; reverse primer, 5′-AAGGGTCTCCAGAAACACCCAAGT
(723 bp).
In situ hybridization
Complete rat spinal cords were dissected out and the whole cords
were stored in RNAlater (Qiagen, Valencia, CA) at −80◦ until
use. Total RNA was extracted by using Qiagen RNeasy Mini kits
(Qiagen, Valencia, CA). Five micrograms of total RNA was sub-
ject to cDNA synthesis with oligo-dT15 primer and SuperScript II
Reverse transcriptase (Invitrogen, Carlsbad, CA) for 1 h at 42◦C.
The reverse transcriptase was inactivated, and RNA was degraded
by heating at 95◦C for 5min. Of the 20µl of cDNA obtained
from the synthesis reaction 5µl were directly added to the
PCR reaction using a PCR Mastermix kit (Eppendorf, Hamburg,
Germany) containing 1µM gene-specific primers. The primer
used in this study was designed by the Invitrogen-OligoPerfect™
Designer program (Invitrogen, Carlsbad, CA). Non-radioactive
single-stranded digoxigenin cRNA probes were used for in situ
hybridization using methodology reported previously (Zhu et al.,
2007). Briefly, single stranded, digoxigenin-labeled antisense and
sense probes are transcribed in vitro using T7 and Sp6 RNA poly-
merase (Promega). The probe sequence for AADC is 523–927 bp
(GenBank U31884), 404 bp product. The probe sequence used
for TAAR1 is 400 bp long (GenBank AF380186). Hybridization
was carried out at 68◦C overnight with 3µg/ml digoxigenin-
labeled antisense cRNA probe. Sense probes were used at identical
concentrations and development reaction as a negative control.
Sections were washed with concentrated standard saline citrate
(and then incubated with anti-digoxigenin-AP Fab fragments
(1:5000, Roche) in blocking buffer overnight at 4◦C. The color
development reaction was carried out in the dark and neutralized
with color stop buffer (10mM Tris, pH 5, 1mM EDTA). Slides
were then dehydrated through a series of alcohol washes, cover-
slipped with Vectamount (Vector Labs) and images were captured
on a Nikon E800 light microscope (Nikon ACT-1 software).
Immunohistochemistry
Sprague-Dawley rats were anesthetized with urethane
(1.5mg/kg), perfused with 1:3 volume/body weight of prefix
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(0.9%NaCl, 0.1%NaNO2, 1 units/1ml heparin) followed by
equal volume/body weight of Lana’s fixative (4% paraformalde-
hyde, 0.2% picric acid, 0.16M PO3); pH 6.9. In a small subset
of experiments, P25 rats with and without a transection were
used. In many of the experiments, Fluorogold, which does not
cross the blood brain barrier, was injected intraperitoneally 24 h
prior to sacrifice to retrogradely label most spinal motoneurons
(Ambalavanar and Morris, 1989; Merchenthaler, 1991). The
spinal cords were then isolated and post-fixed for 1 h in Lana’s
fixative then cryoprotected in 10% sucrose, 0.1M PO3 until
sectioned into 10 um thick sections on a cryostat and processed
for immunohistochemistry. All incubations and washes were
performed in 0.1M PO3-buffered saline containing 0.3% triton
X-100 (PBS-T). Tissue was washed overnight in PBS-T at 4◦C
followed by incubation in primary antibody for 48–72 h. Slides
were then washed three times for 30min and incubated in
secondary antibody. The concentrations for the antibodies can
be found in Table 1. In all experiments, omission controls were
used for the primary antibodies. In addition, tyramine, TAAR1,
and TAAR4 pre-absorption controls were performed with used
antibody concentrations (1:100 and 1:1000) absorbed with
20µg/100µl of antigen (from respective antibody suppliers) for
1 h prior to incubation. As reported by the supplier (Chemicon)
the tyramine antibody has >50,000-fold selectivity over its pre-
cursor amino acid (tyrosine), >40,000 selectivity over dopamine,
and 800-fold selectivity over the trace amine octopamine. Images
were photographed with a Nikon (Tokyo, Japan) digital camera
through a Nikon E800 microscope or using an Olympus FV1000
inverted confocal microscope. Images were processed using Corel
Draw (Corel, Ottawa, Ontario, Canada).
Table 1 | Antibodies used for immunohistochemistry expression.
Primary antibody Secondary antibody Tertiary
Rabbit anti-tyramine 1:1000
(Chemicon)
Biotin anti-rabbit 1:250
(Jackson
Immunoresearch)
Extravidin Cy3
1:1000
(Sigma)
Rabbit anti-TAAR1 1:1000
(Lifespan Biosciences)
Rabbit anti-DDC 1:00
(Biomol Sciences)
cy3 anti-rabbit 1:250
(Jackson
Immunoresearch)
Rabbit anti-tyramine 1:100 or
1:1000
(Chemicon)
Rabbit anti-TAAR1 1:1000
(Lifespan Biosciences)
Sheep anti-DDC 1:100
(Biomol Sciences)
FITC anti-sheep 1:100
(Jackson
Immunoresearch)
Goat anti-TAAR4 1:100
(Santa Cruz Biotechnology)
cy3 anti-goat 1:250
(Jackson
Immunoresearch)
Mouse anti-NeuN 1:50
(Chemicon)
FITC anti-mouse 1:100
(Jackson
Immunoresearch)
Lipophilic dye labeling
A P7 rat was anesthetized with isoflurane via inhalation for tho-
racic cord transection. Following dorsal laminectomy to expose
lower-thoracic segments of the cord, one section of the cord
between T8 and T12 was removed using surgical microdissec-
tion scissors. One week later the cord was isolated and preserved
in 2% paraformaldehyde fixative, then suspended in agarose gel
and labeled with the carbocyanine dye DiI. Crystals of DiI were
placed at the cut surface of ventral funiculi. The dye was allowed
to diffuse to identify gray matter projections sites.
Electrophysiology
Sprague-Dawley rats P0-5 were decapitated, eviscerated, and
placed in a bath containing oxygenated (95% O2, 5% CO2) arti-
ficial cerebral spinal fluid (aCSF) containing the following (in
mM): 128 NaCl, 1.9 KCl, 1.2 KH2P04, 26 NaHCO3, 2.4 CaCl2,
1.3 MgSO4, and 10 glucose (pH of 7.4). The spinal cord was
exposed by a ventral vertebrectomy and carefully dissected out
of the body cavity leaving the dorsal and ventral roots attached.
The spinal cord was secured with insect pins to a chamber
with Sylgard (Dow) on the bottom. Glass suction electrodes
were applied to dorsal and/or ventral roots, after which the
preparation was allowed to recover for at least 1 h before exper-
imentation at room temperature. The ventral root electroneu-
rographic activity was amplified (10,000x), band-pass filtered
at 10–3000Hz, and digitized at 5 kHz (Digidata 1321A, 16-bit;
Axon Instruments). Data was captured on a computer with the
pCLAMP acquisition software (v8-9, Molecular Devices; Union
City, CA). Electrophysiological data analysis was performed using
pCLAMP analysis software (Clampfit) or software written in-
house using MATLAB. Statistical comparisons were made using
ANOVA, Student’s t-test, or paired t-test. The means is reported
as mean± SD.
Motor activity was monitored using glass suction electrodes
attached to ventral lumbar roots, typically bilaterally to L2 and
L5. Changes in levels of motor activity were quantified by first
applying a RC high-pass filter at 1Hz to reduce drift, then
calculating the root mean square of a representative ventral
root signal, and comparing 100 s periods before application of
the TAs and monoamines and during their period of maxi-
mal response. Changes were expressed as a percent increase
over baseline. L2 ventral root activity primarily indicates activ-
ity in flexors, while L5 ventral root activity primarily indi-
cates activity in extensors (Kiehn and Kjaerulff, 1998). LLA was
defined as an alternation between right and left L2 ventral roots,
with each L2 ventral root alternating with the L5 root on the
same side. LLA was analyzed using the in-house MATLAB soft-
ware, SpinalMOD (Hochman et al., 2012), which calculated
the frequency, peak amplitude, and phase, which was calcu-
lated using the middle of the burst (Matsushima and Grillner,
1992).
To evoke the reflexes, constant current stimuli were applied to
the dorsal roots while motor activity was recorded from ventral
lumbar roots, typically L5. Stimulus intensities were 500µA and
durations ranging from 100 to 500µs. For experiments examin-
ing motoneuron activity in the absence of synaptic transmission,
reflexes were abolished after switching from regular aCSF to
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with high Mg2+ (6.5mM)/low Ca2+ (0.85mM) aCSF or zero
Ca2+ aCSF.
Neurochemicals, which were stored in 10 or 100mM
stock solutions at −20◦C, were added to a directly oxy-
genated static bath (typically 30mL) with drug equilibration
achieved via rapid recirculation using several syringe-based fluid
removal/replacement events. Solution exchange was achieved by
replacing the bath aCSF at least three times. Neurochemicals
were obtained from Sigma-Aldrich (St. Louis, MO). N-methyl-
D-aspartate (NMDA) (3–5µM), 5-HT (50µM), noradrenaline
(50µM), and dopamine (50µM) were applied at concentrations
comparable to those used previously in neonatal rat (Cazalets
et al., 1995; Kiehn and Kjaerulff, 1996; Kjaerulff and Kiehn, 1996;
Cowley and Schmidt, 1997; Kremer and Lev, 1997; Kiehn et al.,
1999; Sqalli-Houssaini and Cazalets, 2000; Barriere et al., 2004).
The following TAs were used: tryptamine (50µM), tyramine (1–
100µM), and PEA (50–100µM). TA doses were chosen to match
those of the monoamines under the assumption that they have
equivalent transporter uptake and degradation following exoge-
nous application. Due to the efficiency of the monoamine trans-
porters, it has been estimated that the actual dose at receptor sites
is∼1/30th that applied (Murray et al., 2011). The aromatic amino
acids tyrosine, tryptophan, and phenylalanine were applied at
doses between 100 and 200µM. The non-specific 5-HT receptor
antagonist methysergide was applied at 1–10µM. The serotonin
(SERT), dopamine (DAT), and noradrenaline (NET) transport
inhibitors applied were: citalopram (1µM; a SERT inhibitor),
buproprion (1µM; a DAT inhibitor), and clomipramine (5µM;
a SERT and NET inhibitor). The vesicular monoamine transport
(VMAT) inhibitor, reserpine, was applied at 10µM. The organic
cation transport (OCT) inhibitors, pentamidine was applied
at 200µM. The protein synthesis inhibitor, cycloheximide, was
applied at 100µM.
RESULTS
ANATOMICAL SUBSTRATE FOR TA ACTIONS IN THE SPINAL CORD
AADC and tyramine are widely expressed in the spinal cord
In situ hybridization and immunohistochemistry carried out in
adult rat lumbar spinal cord showed that AADC was detected
with widespread labeling throughout the spinal cord (Figure 1).
AADC expression was most notable around the central canal, the
ventral funiculus, and in ventral neurons, including motoneu-
rons. There was also some nuclear labeling as seen before (Mann
and Bell, 1991). AADC immunolabeling around the central
canal included the previously reported D cells (Jaeger et al.,
1983; Li et al., 2014). Immunohistochemical staining was under-
taken as shown in Figures 1B,C. We observed clear AADC
immunolabeling in neurons associated with the central canal, in
axonal projections in the ventral funiculus, and in blood vessel
endothelia where AADC activity is known to be high (Hardebo
et al., 1979; Nagatsu et al., 1988; Li et al., 2014; Pfeil et al.,
2014).
Next, immunolabeling studies on AADC and tyramine, were
conducted in the neonatal spinal cord (Figure 2). This age was
chosen to match the age at which the subsequent electrophys-
iological studies were undertaken. AADC labeling was similar
to that found in the adult. Labeled spinal neurons were most
FIGURE 1 | In situ hybridization (A) and immunohistochemistry (B,C)
reveal AADC labeling throughout the adult spinal gray matter. (A) Left
Low power magnification of AADC antisense in situ hybridization. Right
Sense and RNAase treatment at right confirms specificity of antisense
probe. Arrows point to putative motoneurons with perinuclear labeling, and
putative D cells below the central canal. (B) Top Intense AADC
immunolabeling is found in blood vessels (black arrows) and in the D cells
(yellow arrows) and in the ventromedial white matter (black arrowheads).
Note that some AADC+ neurons are also found in the dorsal central canal.
Bottom Higher power image of central canal region (outlined). Blood
vessels are identified with black arrows and AADC+ neurons with yellow
arrows. (C) AADC+ terminal arborizations surrounding motoneurons. Most
of these arborizations are presumably from descending monoaminergic
systems. Bottom panel is a negative control omission of primary antibody.
Scale bars: (A), 250µm; (B), 100µm top, 50µm, bottom; (C), 25µm.
notable adjacent and ventral to the central canal, the ventral
funiculus, and in ventral neurons, including putative motoneu-
rons (Figure 2A). As observed in the adult, but more strikingly,
central canal AADC+ neurons projected ventrally in a stream of
cells with subsequent termination of presumed axonal projections
in the most medial portion of the ventral funiculus (Figure 2A,
right). AADC+ neurons were also found in the lateral regions
near the central canal as well as in the dorsal horn (not shown),
although more rarely.
To determine whether cells at the central canal could have
axonal projections to the ventral funiculus, DiI crystals were
applied to various ventral funicular regions in the fixed lum-
bar spinal cord of a P14 rat 1 week after thoracic spinalization.
When dye placement contacted the midline tract, central canal-
associated cells were retrogradely labeled, confirming that cells
consistent with the location of D cells can project to the ventral
funicular white matter tract (Figure 2B).
Tyramine immunolabeling was characterized by enormous
variability between animals, ranging from widespread to near-
absent. This variability may reflect the dynamic sensitivity of tyra-
mine to rates of synthesis and degradation. Expression patterns
included preferential ventral horn labeling, particularly associated
Frontiers in Neural Circuits www.frontiersin.org November 2014 | Volume 8 | Article 134 | 4
Gozal et al. Trace amines activate spinal locomotion
FIGURE 2 | AADC neuronal subpopulations in the neonatal rat lumbar
spinal cord. (A) Left Low power transverse spinal cord section (10µm) of
AADC immunolabeling. Superimposed is an outline of the spinal cord (black)
with interior white lines approximately identifying dorsal and ventral gray
matter and central canal region. Note strongest labeling is associated with D
cells intermingled with epithelial cells surrounding the central canal (top
arrow). Also, note the associated vertical row of cellular labeling projecting
ventrally, and bilateral white matter labeling in the ventral funiculus (bottom
arrow). There is also weak AADC immunolabeling in putative motoneurons (in
lamina IX below dotted lines). Right Three panels showing higher power
images from separate sections illustrate the diversity of AADC labeling in the
ventral medial gray matter region. Epithelial cell layer surrounding central
canal is outlined while blue arrows point to example D cells. Common to all is
the vertical stream of projections with intermingled cells ventral to the central
canal. These appear to end in a white matter tract in the ventral funiculus
(yellow arrowheads). Last panel at right is a z-stack of 25, 0.4µm consecutive
images. Note the AADC+ blood vessel at bottom right identified by yellow
arrowheads. (B) Central canal cells project to the ventral funiculus. DiI
crystals were placed on fixed lumbar spinal cords at the medial ventral
funiculus or just lateral to it and allowed to diffuse to identify gray matter
projections sites. Shown are two 70µm thick transverse sections (a,b) from
a P14 rat 1 week after with a mid-thoracic spinalization. Images are presented
as grayscale with contrast enhancement. Note that when dye placement
contacts the midline tract, neurons associated with the central canal are
retrogradely labeled. Panels at right are magnified images to highlight
retrogradely-labeled neurons in the central canal (corresponding arrows).
Scale bars are: (A), 100µm (left) 50µm (right three); (Ba,Bb), 100 and 25µm
for left and right images, respectively.
with the central canal and in motoneurons (Figures 3A,B). To
increase detectability and further demonstrate that tyramine
immunolabeling was neuronal, we preincubated spinal cords in
100µM tyramine for 2 h. Tyramine labeling co-localized with the
neuron specific marker NeuN, including in retrogradely-labeled
Fluorogold+ motoneurons (Figure 3C).
Tyramine commonly co-expressed with AADC in central canal
D cells, in the ventral stream of cells at the midline, and in
the ventral funiculus (Figure 3D). These results are consistent
with the notion that D cells and related midline neurons syn-
thesize tyramine. We also observed co-labeling in putative spinal
motoneurons (Figure 3E).
Trace amine-associated receptor expression in the spinal cord
Given that 17 TAAR rat genes have been identified, we tested for
the presence of TAAR gene expression in the spinal cord. RT-PCR
was undertaken on total RNA prepared from neonatal rat spinal
cord of both sexes. We observed detectable transcripts for TAARs
1–6, 7a, 8a, and 9 (Figures 4A,B). Because TAAR1 is the only
receptor for which there has been detailed study, we also under-
took in situ hybridization for TAAR1 in the neonate. Widespread
spinal cord labeling was observed including around the central
canal and in the ventral horn region associated withmotoneurons
(Figure 4C).
Immunolabeling for both TAAR1 and TAAR4 was found
throughout the neonatal spinal cord, including in motoneurons
and in neurons around the central canal (Figures 4D,E). TAAR1
and TAAR4 labeling in all neurons appeared intracellular, consis-
tent with previous reported results for TAAR1 (Miller, 2011). A
cytoplasmic location of ligand and receptor (e.g., tyramine and
TAAR1) supports intracellular activation of signal transduction
pathways, as suggested previously (Miller, 2011). The presence of
TAAR1 and TAAR4 provides for actions mediated by tyramine
and PEA, and tryptamine and PEA, respectively (Borowsky et al.,
2001; Bunzow et al., 2001).
TA ACTIONS ON MOTOR AND LOCOMOTOR ACTIVITY IN VITRO
To examine whether tyramine, tryptamine, and PEA increased
motor excitability, population motor activity was recorded
from a lumbar ventral root before and after their application.
As shown in Figure 5A, tryptamine and tyramine increased
motor activity while PEA did not. To test whether the TAs acted
directly on motoneurons, chemical synaptic transmission was
minimized by replacing the regular aCSF with one having high
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FIGURE 3 | Tyramine expression in subpopulations of spinal cord
neurons and co-expression with AADC. (A) Tyramine is expressed in cells
around the central canal and in putative motoneurons. Fluorescence is
minimal following exclusion of primary antibody and greatly reduced in the
presence of pre-absorbed antigen. (B) Tyramine expression patterns are
highly variable. Shown are examples of preferential labeling in ventral gray
matter (left) and in association with the central canal (middle and right). (C)
Preincubation in tyramine leads to widespread neuronal labeling. The isolated
spinal cords of P2 rat were pre-incubated in tyramine for 2 h. The day before
the treatments, the rat pups were injected with Fluorogold to retrogradely
label motoneurons (left). Column 2 shows immunostaining for tyramine.
(Continued)
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FIGURE 3 | Continued
Column 3 provides immunostaining for the neuron-specific marker, NeuN.
Column 4 is a merge of the trace amine with NeuN to show that tyramine is
observed in many neurons, including motoneurons. (B) AADC and tyramine
labeling in D cells associated with the central canal (yellow arrows; left panels
for each pair) and its ventral cellular projection stream appearing to terminate
at a midline tract in the ventral funiculus (right panels in each pair). White
arrows identify ventral funiculus. Note D cells, ventral midline cells, and
ventral funiculus are co-labeled. (C) AADC and tyramine immunolabeling in
putative motoneurons. While AADC produces more uniform cytoplasmic
labeling (left), tyramine labeling includes larger puncta which are not
co-labeled in merged image at right. All images in B and C are high power
confocal images with an optical section of 0.4µm. Scale bars are: (A), 20µm,
(B), 10µm; (C), 100µm; (D,E), 20µm.
FIGURE 4 | TAARs are expressed in neonatal rat spinal cord. (A) RT-PCR
evidence of TAAR expression in both sexes. In males, TAARs 2,5, and 6
expression was weakest, and in females, TAARs 2,6, and 9 were weakest.
(B) RT-PCR series directly comparing TAAR1 and TAAR4 expression in both
sexes as these receptors are known to be activated by trace amines. (C)
TAAR1 mRNA expression in spinal neurons. In situ hybridization reveals
TAAR1 labeling throughout the P2 rat spinal cord ventral horn (compare
sense to antisense). Highlighted regions in sense panel approximately
identify same central canal and motor nucleus location in antisense panels.
(D) TAAR1 receptor immunolabeling is found in many spinal neurons,
including those associated with the central canal (asterisks; left), and in the
ventral horn, including putative motoneurons (right). Note thread-like
projections adjacent to epithelial cells with expansion in central canal interior.
(E) TAAR4 receptor immunolabeling is also found in many spinal neurons and
appears to localize in cells ventral to the central canal (left) and in the gray
matter ventral horn, including putative motoneurons (right). All images are
grayscale negatives. Scale bars: (C), 100µm; (D,E), 25µm. Confocal images
in (D,E) were taken at 0.30µm optical section thickness.
Mg2+/ low Ca2+ or in nominally zero Ca2+ (Shreckengost
et al., 2010). Under these conditions, dorsal root stimulation-
evoked reflexes were abolished (Figure 5B1). Subsequently,
tryptamine and tyramine still increased motor activity
(Figures 5B2,C).
NMDA is commonly co-applied with 5-HT to produce a sta-
ble locomotor-like rhythm in the isolated spinal cord maintained
in vitro with a coordination comparable to normal locomo-
tion when limbs remain attached (Sqalli-Houssaini et al., 1993;
Kjaerulff and Kiehn, 1996; Hayes et al., 2009). This LLA can be
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FIGURE 5 | Tyramine and tryptamine increase motor activity. (A)
Tryptamine and tyramine increased lumbar ventral root activity while PEA
was without effect. (B1) Dorsal root stimulation evoked reflexes (left) were
abolished when synaptic transmission was blocked in high Mg2+ (6.5mM),
low Ca2+ (0.85mM) containing aCSF (right). (B2) Under these conditions,
direct excitatory actions were still observed for tryptamine and tyramine.
(C) Changes in ventral root activity were quantified compared to baseline
activity levels with and without synaptic transmission (∗ indicates p < 0.05
and ∗∗ indicates p < 0.01). Samples sizes are listed.
monitored from ventral roots as left/right and ipsilateral alterna-
tion of bursts between flexors (L2) and extensors (L5) (Figure 6A)
(Kiehn and Kjaerulff, 1998). To test for locomotor promoting
actions of the TAs and classical monoamines, we co-applied
NMDA at concentrations that never produced stable LLA on its
own (3–5µM; n = 15). Tryptamine (n = 14/19), tyramine (n =
24/26), PEA (n = 10/10), NA (n = 14/14), DA (n = 14/14),
and 5-HT (n = 24/24) reliably recruited rhythmic motor activ-
ity. Of those expressing rhythmic motor activity, a locomotor-like
rhythm comparable to 5-HT was observed for DA, NA and
the TAs with the following incidences: DA (5/14), NA (2/14),
tryptamine (13/14), tyramine (12/24), and PEA (3/10). Examples
are shown in Figures 6B–G. In these instances, all amines led
to bursting at frequencies statistically indistinguishable from 5-
HT (Figure 7A). Since the bursting patterns produced by the
TAs are often similar to 5-HT, the TAs likely recruit the same
pattern-generating circuits. Tyramine (n = 5/24; Figure 6H) and
dopamine (n = 3/14) also produced a second rhythm that was
significantly slower, but with comparable locomotor-like coor-
dination (Figure 7B). DA (n = 9/14; 0.04 ± 0.02Hz) and NA
(n = 12/14; 0.02 ± 0.02Hz) also produced rhythmic patterns
of continuous bursting that were non-locomotor-like in coor-
dination and significantly slower than 5-HT-evoked rhythms
(Figure 7C).
Interestingly, tryptamine (n = 1/14), tyramine (n = 8/24),
and PEA (n = 7/10) were able to generate a bursting pattern
never seen with the monoamines in this preparation. The pattern
was more complex with episodic bouts of bursting (Figure 7D).
During these bouts, burst frequencies were statistically indistin-
guishable from 5-HT locomotion. Episodic bouts of bursting
were variable but usually concurrent across roots and alter-
nated with comparatively quiescent periods at very slow average
frequencies (Figure 8). For tyramine, bursting patterns intercon-
verted between continuous locomotion to episodic bouts in one
experiment. Notably, bouts of episodic bursting were the dom-
inant activity pattern observed for PEA (Figure 7C). Expressed
bouts of episodic bursting were highly variable, containing up to
47 events within an episode and with quiescent periods varying
from 5 to 230 s.
Frequently, there were progressive increases and decreases in
the locomotor burst amplitude within each episode, which were
noticeable in at least some bouts for all TAs tested (Figure 8).
Similarly, locomotor frequency could be seen to wax and wane
during these bouts, supporting a sinusoidal drive to the CPG.
This is highlighted in Figure 8A with progressive increases then
decreases in burst amplitude, and locomotor frequency are
further quantified in Figure 8D.
EVIDENCE THAT THE TAs ACT AT UNIQUE BINDING SITES
Differences in receptor pharmacology
5-HT is thought to activate spinal locomotor circuits via 5-HT2
and 5-HT7 receptors (Madriaga et al., 2004; Liu and Jordan, 2005;
Liu et al., 2009). Methysergide is a high affinity non-selective 5-
HT1, 5-HT2, and 5-HT7 receptor antagonist (Madriaga et al.,
2004) and a tryptamine binding site antagonist (Martin et al.,
1988). To determine if the TAs and other monoamines had a
similar sensitivity to methysergide as 5-HT, methysergide was
added to TA and monoamine–induced rhythms (with NMDA)
at progressively increasing doses (Table 2). Tryptamine was more
sensitive than 5-HT tomethysergide block. Tyramine was variably
sensitive to methysergide block, while PEA, NA, and DA-evoked
LLA was methysergide-insensitive even at the highest dose tested
(10µM). Based on methysergide sensitivity, it appears likely that
tyramine and PEA actions are not dependent on 5-HT recep-
tor activation. Methysergide block of tryptamine-evoked LLA
may be via competitive block at 5-HT receptors and/or at the
methysergide-sensitive tryptamine binding site (Martin et al.,
1988).
Temporal differences in activation onset
When time to burst onset after bath application was examined,
5-HT and NA had rapid burst onset (medians of 7.5 and 2.5 s,
respectively). In comparison, burst onset took dramatically longer
for DA, tryptamine, tyramine, and PEA (medians of 480, 300,
300, and 540 s, respectively; all are p < 0.05) (Figure 9). This sug-
gests that the TAs andDA are not acting predominantly on plasma
membrane metabotropic receptors.
Possible sites of action
TA-evoked locomotor-like activity is independent of the vesicu-
lar monoamine transporter. To test whether TA-evoked actions
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FIGURE 6 | The TAs and monoamines can all produce a continuous
LLA pattern. (A) Experimental setup (left). All of the electrophysiological
experiments use the thoraco-lumbar isolated neonatal rat spinal cord
maintained in vitro. Suction electrodes are placed on lumbar L2 and L5
ventral roots bilaterally to monitor population motoneuron flexor and
extensor activity, respectively. LLA is shown as an alternation between
right and left L2 flexors, with each flexor rhythm alternating with the L5
extensor rhythm on the same side. (B) Typical locomotor rhythms
observed with co-application of 5-HT and NMDA. (C–G) Tryptamine,
dopamine, PEA, NA, and tyramine can also produce a continuous LLA
pattern comparable to 5-HT in the presence of NMDA. (H) Tyramine can
also produce a slower LLA pattern. The upper traces in gray at each
lumbar root represent the rectified/low-pass filtered equivalent of the raw
waveforms below them. Scale bars are 10 s in all panels.
required interactions with the vesicular monoamine transporter
(VMAT), we compared the locomotor-inducing ability of the TAs
to those of 5-HT (always in the presence of NMDA) in bath cham-
bers pre-incubated with the VMAT inhibitor reserpine (>40min)
(10µM; Figure 10A). In the presence of reserpine, 5-HT and
tryptamine evoked LLA in all cords tested (n = 5/5). In com-
parison, tyramine- and PEA-evoked LLA was seen in 4.5 and 3/5
cords, respectively. As reserpine has moderate binding affinity
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FIGURE 7 | Similarities and differences in motor burst phenotypes
observed with the monoamines and TAs. Four characteristic categories
(A–D) describe the range bursting patterns observed. Frequencies varied
depending on the type of bursting. (A) In the neonatal rat,
5-HT/NMDA-induced LLA has a characteristic frequency range, which was
also seen when NMDA was co-applied with the other amines. (B)
Dopamine and tyramine also produced a much slower rhythm, but with the
same flexor-extensor left-right locomotor-like coordination. (C) NA and
tyramine could also produce a much slower rhythm, but without
locomotor-like coordination. (D) Seen only with the TAs, this episodic
pattern is described as “Bouts of LLA superimposed on slow frequency
burst episodes.” LLA and the slower episodic bursts are represented as
overlapping bars in this grouping. The frequencies of slow LLA (B), slow
non-LLA rhythmic bursting (C), and the slow frequency of episodic bursting
(D) were statistically slower than LLA. Asterisks (∗) denote inclusion of an
animal for tyramine in two categories as both behaviors emerged at
different times.
to D2 and D3 dopamine receptors (Toll et al., 1998) and also
interferes with DAT and NET (Yamamoto et al., 2007; Mandela
et al., 2010), non-specific actions including at a PEA binding
site may have accounted for the reduced incidence of LLA with
PEA. Overall, the VMAT inhibitor, reserpine, does not prevent
the expression of TA-evoked LLA.
TA-evoked locomotor-like activity is independent of high-
affinity monoamine transporters located on descending
monoaminergic terminals. The high-affinity monoamine trans-
porters for 5-HT (SERT), DA (DAT), and NA (NET) control
the extracellular concentrations of monoamines and maintain
presynaptic function (Torres et al., 2003). Since the monoamine
transporters are also a substrate for transport of TAs (Xie et al.,
2007), a mechanism by which the TAs could exert their action
is by transporter-mediated presynaptic uptake at descending
monoaminergic terminals. For example, the TAs could elevate
extracellular monoamines by competing for uptake or displacing
biologically active biogenic amines from their storage leading to
efflux via reverse transport (Premont et al., 2001). Additionally,
once transported intracellularly, they could act on presynaptic
TAARs to alter basal activity (Miller, 2011).
To explore this, we compared the motor rhythm-inducing
actions of the TAs or monoamines to those seen in the presence
of co-applied SERT, DAT, and NET transport inhibitors (citalo-
pram, 1µM; bupropion, 1µM; and clomipramine, 5µM, respec-
tively). Given the variability in expression of TA-evoked responses
observed in earlier experiments, we undertook most subsequent
studies using littermate pairs of spinal cords in the same experi-
mental chamber (Figure 10B). 5-HT-evoked LLA was not signifi-
cantly altered (n = 12; 0.16± 0.06Hz without vs. 0.15± 0.04Hz
with inhibitors). Similarly, PEA-evoked LLA was unaffected by
the transport inhibitors in 9 animals (0.17 ± 0.09Hz vs. 0.15 ±
0.06Hz). Tryptamine-induced motor rhythms were comparable
in 7/8 animals and blocked in another (0.11± 0.03Hz without vs.
0.08 ± 0.06Hz with inhibitors). Tyramine-evoked actions were
blocked in 2/11 animals. Interestingly, tyramine block occurred
in both spinal cords of a single chamber, littermate-paired exper-
iment (Figure 10Bb2). In the remaining 9 neonates, LLA was not
blocked (0.08± 0.07Hz before vs. 0.12± 0.10Hz in the presence
of inhibitors). Thus, the TAs can activate motor rhythms inde-
pendent of actions on high-affinity monoamine transporters in
the isolated spinal cord. As no spinal neurons express NET, SERT,
or DAT, direct actions on spinal circuits are strongly implicated.
Intracellular transport of tyramine and tryptamine are required
for locomotor-like activity: dependence on low affinity Na+-
independent membrane transporters. OCTs belong to a family
of Na+ and Cl− independent bidirectional solute carrier (SLC)
transporters, SLC22A (Jonker and Schinkel, 2004). The fam-
ily contains three subtypes (OCT1-3) and all appear widely
expressed in the spinal cord (Allen_Spinal_Cord_Atlas, 2009).
Tyramine was shown to be the best physiological substrate for
OCT1 and OCT2 (Schomig et al., 2006). In comparison, DA,
NA, and 5-HT clearance was too low for a primary role in trans-
port while tryptamine and PEA actions were not tested. The
plasma membrane monoamine transporter (PMAT) is another at
Na+-independent transporter with comparable pharmacological
and transport properties to the OCTs. PMAT transports biogenic
amines including tyramine and tryptamine (Engel and Wang,
2005) while PEA acts as a potent cis-transport inhibitor (Ho et al.,
2011). PMAT has widespread expression in neurons in brain and
spinal cord (Engel and Wang, 2005; Allen_Spinal_Cord_Atlas,
2009).
Pentamidine is an OCT inhibitor with IC50 values of 0.4 and
5.1µM for OCT1 and OCT2, respectively (Jung et al., 2008).
The effects of pentamidine were only tested on tyramine and
tryptamine-evoked LLA (Figure 11A). Tyramine-induced LLA
(0.19 ± 0.02Hz) was blocked in all 8/8 cords tested (p < 0.001).
Tryptamine was also tested in 5 of these animals. Pentamidine
completely blocked tryptamine-induced LLA in 2/5 animals with
reduced overall frequency in the other 3 animals (0.16 ± 0.02
to 0.07 ± 0.07Hz; p < 0.05). Depressant actions were associated
with dramatic reductions in the magnitude of observed activity
(Figure 11B). When 5-HT was subsequently applied, LLA re-
emerged in all 5 animals (0.17± 0.08Hz) supporting an indepen-
dence of pentamidine actions on 5-HT-evoked LLA (Figure 11B).
It is noteworthy that pentamidine is also a NMDA receptor
non-competitive antagonist, but did not prevent expression of 5-
HT/NMDA LLA (Reynolds and Aizenman, 1992; Reynolds et al.,
1993).
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FIGURE 8 | The TAs produce episodic bursting patterns that are
different than the regular pattern seen with 5-HT in the presence of
NMDA. (A–C) Tyramine, tryptamine, and PEA can produce episodic
rhythmic motor bursting patterns with bouts of locomotor-like bursting
interrupted by quiescent periods. Bottom panels are expanded time scales
of time periods identified by green bars to show in detail the
locomotor-like coordination. Typically, episodic bursts are concurrent on all
ventral roots. (D) Episodic bouts of locomotor-like activity are frequently
associated with wax and wane changes in amplitude and frequency.
Shown is the bout highlighted by the box on r-L2 in panel A with overlaid
plots of instantaneous frequency (blue) and peak amplitude of the rectified
response (green). Note the trend for amplitude and frequency to increase
then decrease over the episodic bout of locomotion. Events within the
shaded box emphasize the dominance of higher frequency/higher
amplitude values in the middle of the episode of bursting. The upper
traces in gray at each lumbar root represent the rectified/low-pass filtered
equivalent of the raw waveforms below them. Scale bars are 100 s in top
panels and 10 s in bottom panels.
Evidence that the TAs can be endogenously synthesized from
their aromatic amino acid precursors to generate locomotor-
like activity. Intrinsic spinal cord AADC activity should enable
endogenous synthesis of the TAs from their precursor aromatic
amino acids (AAAs), phenylalanine (for PEA), tyrosine (for tyra-
mine), and tryptophan (for tryptamine). We therefore tested
whether bath application of AAAs lead to the expression of rhyth-
mic motor activity. Tyrosine (n = 5), tryptophan (n = 3), or
phenylalanine (n = 3) were applied at doses between 100 and
200µM with or without NMDA. In two additional experiments,
the AAAs were co-applied. In all cases, no obvious maintained
motor rhythms were observed (not shown).
As in vitro experiments are undertaken in the absence of essen-
tial amino acid containing media, we explored whether the lack of
observed effect was related to lack of substrate availability. In the
developing neonate, available cytoplasmic AAAs may be prefer-
entially directed toward protein synthesis. We therefore tested the
effects of complete arrest of protein synthesis using cycloheximide
(100µM). Cycloheximide is known to increase intracellular levels
of AAA (Beugnet et al., 2003) and inhibition is mostly reversible
within 1 h (Abbas, 2013).
Eight dual experiments were conducted with pairs of spinal
cords from littermates recorded simultaneously in the same
bath chamber (n = 16 total sample). In the presence of NMDA
and cycloheximide, motor rhythms with epochs consistent with
a locomotor-like coordination were observed in all 16 spinal
cords. Activity was comparatively fast at 0.31 ± 0.09Hz but
appeared to be weaker and more variable than that seen with
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Table 2 | Methysergide preferentially blocks tryptamine and
5-HT-induced locomotor like activity.
Drug Methysergide dose
1µM 2µM 5µM 10µM
5-HT 2/8 5/5
Tryptamine 6/6
Tyramine 1/6 0/5 2/5 0/3
PEA 0/3 0/3 0/3 0/3
Noradrenaline 0/4 0/4 0/4 0/4
Dopamine 0/6 0/4 0/4 0/4
Following induced LLA, methysergide was applied in progressively increasing
doses as shown to assess differential monoamines agonist sensitivity to block.
FIGURE 9 | Dopamine and the TAs take a significantly longer time to
initiate bursting than 5-HT and NA. The box-and-whisker plots show the
time it takes to initiate bursting (always in the presence of NMDA). The red
line is the median and individual outliers, defined as more than 1.5 times
the interquartile range were observed for 5-HT (cross) and for tryptamine at
1800 s (not shown). Asterisk (∗) indicates p < 0.05. Samples sizes are
shown at top.
the monoamines. Cycloheximide was applied before NMDA
(n = 2), after NMDA (n = 5), or co-applied with NMDA (n =
1). Cycloheximide alone produced no observable action, but
episodic LLA emerged with subsequent application of NMDA
(Figure 12A). NMDA applied alone generated some epochs of
weak bursting activity in at least one of the paired cords in 3/5
experiments with subsequent addition of cycloheximide lead-
ing to episodic LLA on spinal cord pairs (Figure 12B). In the 3
experiments with only bath applied NMDA, spontaneous burst-
ing was also seen prior to NMDA application. Overall increases in
initial cord excitability seen may have been due to residual cyclo-
heximide from prior days. In one of these experiments, NMDA
alone generated robust bursting though subsequent application of
cycloheximide led to a clearly strengthened and regularized LLA
(Figure 12C).
As described earlier, episodic tyramine- and PEA-evoked an
episodic form of LLA never seen with the classical monoamines
(in 33 and 70% of animals, respectively; Figure 7). After cyclohex-
imide, episodic bouts of LLA appeared in 69% (11/16) of tested
animals, 4 of which expressed rhythms that were distinctly PEA-
like (Figure 12D). LLA coordination across recorded ventral roots
is depicted in a polar plot of relative burst timing (Figure 12E).
Thus, in the absence of protein synthesis, an increased bioavail-
able source of amino acids enabled the expression of episodic
LLA, a distinctive feature of TA-evoked motor rhythms.
DISCUSSION
The neonatal rat spinal cord was shown to contain AADC, the
essential synthesis enzyme for TA biosynthesis from their amino
acid precursors, as well as their cognate G protein-coupled recep-
tors (TAAR1 and TAAR4) that together define the essential sub-
strates to exert biological actions. Whether and how this intrinsic
spinal aminergic modulatory system is recruited is unknown,
but exogenously provided TAs clearly promote motor pattern
generating circuits. To exert their modulatory actions TAs show
dependence on intracellular translocation via Na+-independent
transporters, consistent with prominent intracellularly located
TAARs. Unlike the classical monoamines, the TAs can also gen-
erate an episodic form of LLA. That episodic motor rhythms are
also seen following increases in precursor amino acid availability
supports the endogenous TA biosynthesis as a means to promote
motor circuit activation.
ANATOMICAL OBSERVATIONS
AADC and tyramine expression in the spinal cord
In both adult and neonate, we regularly observed AADC labeling
in cells surrounding the central canal (D cells), in a ventral stream
from this region, and in blood vessels. Central canal-related label-
ing is consistent with previous reports in rat, mouse, and monkey
(Jaeger et al., 1983; Nagatsu et al., 1988; Barraud et al., 2010; Li
et al., 2014; Wienecke et al., 2014). Labeling in blood vessels has
also been reported (Jaeger et al., 1983; Li et al., 2014). AADC
immunolabeling was also seen in other gray matter areas and
in a midline ventral funiculus white matter bundle (Wienecke
et al., 2014). This white matter tract likely represents axon pro-
jections of D cells as we observed that DiI applied to this region
retrogradely labeled central canal cells. In the neonate, we also
observed a ventral collection of AADC+ midline cells emanating
from the central canal. These cells may represent a ventral “migra-
tory stream” of active neurogenesis since Wienecke et al. (2014)
observed that D cells are Neun−/doublecortin+ in adult rat,
and thus likely to be newly generated neurons or neural precur-
sors. Interestingly, motoneurons appeared to be weakly AADC+
though neither in situ hybridization nor immunodetection of
AADC has been previously reported in rat spinal motoneurons.
To support this observation, we mined our earlier microar-
ray expression profiling study on laser capture microdissected
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FIGURE 10 | TA-induced LLA is not principally via uptake by
high-affinity plasma membrane or vesicular monoamine
transporters. (A) The vesicular monoamine transport inhibitor, reserpine
(10µM), did not prevent TA-induced modulatory actions. Shown is
evoked LLA in two rats (a,b) (B) TA-evoked actions were tested before
and after combined application of the transport inhibitors, citalopram
(1µM; a SERT inhibitor), buproprion (1µM; a DAT inhibitor), and
clomipramine (5µM; a SERT and NET inhibitor). The transport inhibitors
were usually without effect as shown for tryptamine (a), but could also
depress (b; in this case tyramine) or facilitate LLA (c; in this case
PEA). In all panels, 5-HT and the TAs were always in the presence of
NMDA. Scale bars are 10 s in all panels.
medial and lateral motor column motoneurons (Cui et al., 2006).
Using the present/absent call in Affymetrix Microarray Suite
software, AADC cDNA was detected as present in all sam-
ples of motoneurons. In comparison, tyrosine hydroxylase and
dopamine-β-hydroxylase cDNA were reported as absent.
Tyramine immunolabeling was also seen in AADC-containing
neurons, consistent with AADC-mediated synthesis from tyro-
sine. It is assumed that tryptamine and PEA would also be
synthesized by AADC from their respective amino acid precur-
sors, but could not identify commercially available antibodies
with acceptable specificity for these TAs. While the most con-
sistent labeling observed for tyramine and AADC was in central
canal midline regions and motoneurons, we noted considerable
inter-animal variability. Indeed, the TAs have been described
as protean. Metabolic sensitivity to temporal shifts in substrate
availability may be a defining feature of the AADC-TA-TAAR
modulatory system (Burchett and Hicks, 2006).
Trace amine-associated receptors 1 and 4 in the spinal cord
Previously, in situ hybridization, RT-PCR, and LacZ reporter
expression studies all observed labeled TAAR1 in the brain
(Borowsky et al., 2001; Lindemann et al., 2008) and one report
also examined and detected expression in spinal cord (Borowsky
et al., 2001). While TAARs are thought to be Gs-coupled
(Borowsky et al., 2001), there is also evidence of activation of Gq-
coupled signal transduction pathways (Panas et al., 2012). Here,
RT-PCR identified expression of several TAARs in the neonatal
rat spinal cord, including TAAR1 and TAAR4. We also observed
TAAR1 and TAAR4 immunolabeling in neurons near the cen-
tral canal and in motoneurons. TAAR1 and TAAR4 expression
observed in the spinal cord overlapped with the expression of
AADC and tyramine. Since tyramine and PEA activate TAAR1
and tryptamine and PEA activate TAAR4 (Borowsky et al., 2001),
the TAs have a substrate for biological actions in the spinal cord.
Suggestive immunolabeling evidence of a cytoplasmic location
of both ligand (tyramine) and receptors (TAAR1 and TAAR4)
supports an intracellular activation of signal transduction path-
ways (Miller, 2011). This is fully consistent with exogenously
applied TAs showing dependence on transmembrane transport
and taking longer than 5-HT andNA to exert modulatory actions.
In summary, the mechanisms for TA synthesis and actions are
anatomically coincident, and provide a substrate by which TAs
can produce effects on their own.
ELECTROPHYSIOLOGICAL ACTIONS
When applied alone, the monoamines, tryptamine, and tyramine
increased motor activity, including via direct excitatory actions
on motoneurons. This agrees with a previous study showing that
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FIGURE 11 | OCT/PMAT transport inhibitors depress or block
tryptamine and tyramine-induced LLA. Shown are simultaneous
recordings from littermates in the same chamber. (Aa) Pentamidine
(200µM) depressed tryptamine-induced LLA. (Ab) Following wash,
tyramine-induced LLA was also depressed by pentamidine. In both
(Aa,Ab), LLA re-emerged with subsequent addition of 5-HT (not shown).
(B) Time course of pentamidine-induced depression of tyramine and
tryptamine-induced LLA in the same animal. LLA re-emerges after
application of 5-HT (50µM). Arrows denote time of pentamidine and 5-HT
applications. R-L2 and l-L2 recordings at right present epochs with a
shorter time scale for the periods highlighted by numbered green bars.
Scale bars are 10 s unless otherwise shown.
tyramine can act directly on motoneurons (Kitazawa et al., 1985).
PEA is an agonist at both TAAR1 and TAAR4 receptors (Borowsky
et al., 2001; Bunzow et al., 2001); so their expression in motoneu-
rons should also facilitate motor activity. However, no overt
actions were observed. One possibility is that there is no mem-
brane transporter for PEA in motoneurons. Another possibility is
that TAARs are expressed as heterodimers (e.g., TAAR1/TAAR4)
that preferentially interfere with PEA binding (Babusyte et al.,
2013). Other possibilities include actions on other receptors (e.g.,
Gi-coupled α2-adrenergic) that compete with TAAR1 and TAAR4
mediated actions (Pacifico et al., 2012).
We observed that 5-HT, NA, and DA produced comparable
LLA in the presence of NMDA, consistent with reports of sub-
locomotor doses of NMDA helping to stabilize and regularize
the locomotor rhythm (Sqalli-Houssaini et al., 1993; Cowley and
Schmidt, 1994; Kjaerulff et al., 1994; Schmidt et al., 1998). The
TAs also produced LLA indistinguishable from that seen with the
monoamine transmitters, strongly suggests that the TAs are acting
at the level of the locomotor central pattern generator (CPG)
and recruiting the same pattern-generating circuits. However,
the detailed pattern of activation (which CPG neuron classes are
recruited) may not be the same.
The TAs were also generated an episodic form of LLA not
seen with the monoamine transmitters, and both continuous
and episodic locomotor phenotypes could be observed at dif-
ferent times within an individual animal. Episodic LLA may
represent a physiologic pattern recruited by endogenous mech-
anisms. For example, voluntary wheel running in rats and mice
is episodic, occurring in short bouts separated by longer peri-
ods (Hanagasioglu and Borbely, 1982; Eikelboom andMills, 1988;
De Bono et al., 2006). Whelan et al. (2000) reported sponta-
neous episodes of rhythmic ventral root activity in themouse very
similar to those seen here (Whelan et al., 2000).
Episodic LLA patterns may reflect recruitment of additional
neurons or intrinsic membrane properties that influence the out-
put of the spinal locomotor CPG. This is explored theoretically
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FIGURE 12 | In the presence of NMDA, cycloheximide-induced
accumulation of intracellular amino acids leads to the expression or
facilitation of LLA. Shown are three separate experiments with pairs of
littermate matched spinal cords in the same recording chamber. (A) Following
pre-incubation of cycloheximide (1), applied NMDA leads to the expression of
LLA in both cords (2). Replacement of solution and subsequent application of
NMDA (3) reinstates some bursting in cord, but a full LLA pattern emerges in
both cords only after reapplication of cycloheximide (4). (B) NMDA generated
some spiking in both cords of this pair (1) while addition of cycloheximide led
to LLA in both pairs. (C1) In this pair, some spontaneous excitability was seen
initially (1) and NMDA+ cycloheximide led to coordinated LLA (2). Note the
overall similarity in response in paired spinal cords. (C2) Low-pass filtered
recording of additional recorded LLA activity in rat 2 after cycloheximide and
NMDA. L-L2 activity (black) is inverted and adjacent to r-L2 to show anti-phase
left-right coordination between flexors, and overlapped with r-L5 activity to
show phase coupling with contralateral extensor activity. (D) Comparison to
PEA evoked rhythm. Longer duration recordings with rectified, low-pass
filtered trace compare PEA expression pattern to cycloheximide/NMDA LLA
in two separate animals. Scale bar is 10 s in all (A–D). (E) Phase relationship
of r-L2 burst onset (from 0◦) to l-L2 and r-L5 burst onsets (blue and red
symbols, respectively). The cycle progresses clockwise from 0◦ (in-phase) to
180◦ (out-of-phase) to 360◦/0◦. Events correspond to bursts in lower record
of (D) identified with vertical dotted bars. Timing is consistent with LLA.
Arrow length represents the concentration (r) about the mean angle (Ø). The
inner circle inside the phase diagram denotes the critical r vector calculated
from the Rayleigh’s Z table using α = 0.05 (Zar, 1999).
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in Figure 13A with the assumption that the TA-induced regu-
lar LLA pattern is produced at the CPG level. Episodic mod-
ulation of LLA might occur in neurons that project onto the
CPG (left illustration) themselves producing a much slower
rhythmic synaptic drive onto the CPG. This is consistent with
observed waxing and waning of LLA. Obvious candidate neurons
are the AADC-expressing D cells surrounding the central canal
(described below). Other possible organizations are depicted and
explored in Figure 13A.
While the function of these D cells in the mammal is still
unknown, similarly-located and projecting CSF-contacting neu-
rons in larval zebrafish initiate slow swimming by optogenetic
stimulation. Their genetic silencing reduced the frequency of
spontaneous locomotion, and they provided the necessary tone
for spontaneous forward swimming (Wyart et al., 2009). Based
on the similarity in location, it is not unreasonable to consider
a comparable role for D cells in the mammal. Aside from CSF-
contacting D cells, many other AADC+ neurons were located in
adjacent ventromedial locations. This location is consistent with
ventromedially located interneurons shown to undergo intrin-
sic membrane voltage oscillations including in association with
neurochemicals that induce LLA (Hochman et al., 1994; Tazerart
et al., 2008; Brocard et al., 2013). Thus, D cells, with projec-
tions into the ventral funiculus, and previously reported synaptic
projections toward motor nuclei (Jaeger et al., 1983) repre-
sent a likely source of the episodic modulation of locomotor
activity.
TA ACTIONS ARE MECHANISTICALLY DISTINCT FROM THE
MONOAMINES TRANSMITTERS
The TAs are structurally similar to the classical monoamines and
may act as monoamine receptor agonists. Tryptamine can acti-
vate 5-HT2 and 5-HT7 receptors (Boess and Martin, 1994), on
which 5-HT induced locomotion is dependent (Madriaga et al.,
2004; Liu and Jordan, 2005; Liu et al., 2009), and tryptamine and
5-HT evoke similar locomotor patterns with similar sensitivity
to methysergide block. On the other hand, tyramine and PEA-
evoked LLA appear to have very low affinity to the monoamine
receptors (U’Prichard et al., 1977; Shen et al., 1993; Peddi et al.,
2003). Critically, the TAs including tryptamine require 50–100-
fold longer incubations periods to activate LLA and this differ-
ence is not consistent actions via plasma membrane monoamine
receptors. Therefore, tryptamine may require activation of 5HT
as well as TAARs to generate LLA.
Slower actions were not due to indirect release of monoamines
through their transporters since TA-induced LLA remained
following block of VMAT and the Na+-dependent monoamine
transporters. Instead, prolonged incubations periods are
consistent with observed dependence of tyramine- and
tryptamine-evoked LLA on intracellular transport via low
affinity Na+-independent membrane transporters. Collectively
these observations support TA recruitment of LLA by intrinsic
spinal mechanisms independent of descending monoaminergic
systems.
Notably, DA also took much longer to initiate LLA. Since
DA can be generated in endothelia subsequent to hypoxic
stress (Pfeil et al., 2014) and DA is a low affinity agonist at
FIGURE 13 | Possible network and cellular pathways for TA-mediated
actions. (A) Possible location of TA modulatory actions in the emergence
of episodic LLA. (1) Episodic bursts upstream of the locomotor central
pattern generator (CPG) could include alternating excitation and inhibition.
Putative trace aminergic neurons are the AADC+ D cells. Their location is
within the spinal region responsible for locomotor rhythmogenesis. Their
effect could be to generate a waxing and waning of CPG output to
motoneurons (MN). (2) Modulatory actions within a subclass of CPG
neurons. For example, the synaptic drive provided by the CPG could
interact with slow frequency intrinsic voltage oscillations. (3) Modulatory
actions within motoneurons are not consistent with observed waxing and
waning in locomotor CPG frequency. (B) Putative transport and intracellular
signaling mechanisms for TA actions. The TAs, tyramine and tryptamine,
undergo Na+-independent membrane transport via the PCTs and PMAT,
respectively. PEA transport could include the LATs, which are also
responsible for transport of the precursor aromatic amino acids (AAAs),
tyrosine, phenylalanine, and tryptophan. It is also possible for these TAs to
be made from their AAA precursors in AADC-containing cells. Once inside,
the TAs act on intracellularly-located TAARs to produce Gs-coupled
neuromodulatory responses. The TAs could also be generated via AADC in
some neurons (here neuron A) or from endothelia then transported into
adjacent non-AADC but TAAR-containing neurons to exert neuromodulatory
actions. Abbreviations: PMAT, plasma membrane monoamines transporter;
OCTs, organic cat ion transporters; LATs, large neutral amino acid
transporters; PKA, protein kinase A; cAMKII, calcium/calmodulin dependent
protein kinase II; AC, adenylate cyclase; 5-HTR, 5-HT receptor; TA, trace
amine; TAAR, trace amine-associated receptor.
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TAAR1 in rat (Bunzow et al., 2001), DA-induced LLA may nor-
mally associate with vascular release and subsequent intracellular
neuronal transport via PMAT.
Dependence on transmembrane transport for PEA-evoked
actions was not tested. Biologically, PEA transport is known to
occur via a saturable proton-dependent transport process inde-
pendent of all currently studied OCTs (Fischer et al., 2010).
PEA is also a potent cis-transport inhibitor of PMAT (Ho et al.,
2011). Some PEA transport may occur by Na+-independent
system L amino acid transporter LAT3 (Babu et al., 2003),
which shows widespread expression in the mouse spinal cord
(Allen_Spinal_Cord_Atlas, 2009), as well as by simple diffusion
(Berry et al., 2013).
As reported for TAAR1 in HEK cells (Bunzow et al., 2001;
Miller, 2011), we observed cytoplasmic labeling for TAAR1 and
TAAR4, both of which are activated by the TAs (Borowsky et al.,
2001). A cytoplasmic location of the ligand and the receptor
(e.g., tyramine and TAAR1) would support intracellular acti-
vation of signal transduction pathways (Miller, 2011). Such a
co-localization would not require release from vesicles and could
explain why the TAs do not appear to be found there (Berry, 2004;
Burchett and Hicks, 2006).
Putative transport mechanisms for the TA are shown in
Figure 13B. The TAs, tyramine and tryptamine, can transport
via OCTs and PMAT, respectively, whereas PEA may transport
via LAT3 but more likely via a currently unidentified transporter.
TA biosynthesis can alternatively be generated intracellularly from
aromatic amino acid (AAA) precursors in AADC-containing cells
to act on intracellularly-located TAARs. This would constitute a
form of biochemical integration (Katz and Clemens, 2001). TAs
generated via AADC in some neurons (here neuron A) or from
endothelia can transport into adjacent non-AADC but TAAR-
containing neurons to exert neuromodulatory actions (OCTs and
PMAT transport is bidirectional). Last, as AADC and TAARs
are present in vasculature, TA modulation of vascular function
may lead to secondary actions on neurons (Hardebo et al., 1979;
Nagatsu et al., 1988; Broadley, 2010; Anwar et al., 2012).
TA BIOSYNTHESIS AS A SYMPATHETIC AUTONOMIC CELLULAR
STRESS RESPONSE
Intrinsic spinal cord AADC activity should enable endogenous
synthesis of the TAs from their AAA precursors. However, when
the AAAs were bath-applied, no obvious maintained motor
rhythms were observed. Since intracellular transport of AAAs
may be rapidly sequestered for protein synthesis during this
neonatal period of dramatic growth, we blocked protein synthesis
with cycloheximide in order to increase biochemically access to
AAAs (Beugnet et al., 2003). The effects of cycloheximide were
dramatic with LLA developing in all animals. Additional stud-
ies are required to directly link increases in AAAs to increases
in endogenous TA biosynthesis to induce a neuromodulatory
response. However, emergent LLA included TA-like episodic
bouts including those with burst structures notably comparable
to that seen with PEA.
Access to precursor amino acids for TA biosynthesis may
depend heavily stress-induced protein catabolism. As the TAs
are known sympathomimetics (Branchek and Blackburn, 2003;
Berry, 2004), spinal TAs may function to facilitate motor
responses during strong sympathetic nervous system activation.
For example, marked PEA increases are seen in human urine after
a highly stressful event (Paulos and Tessel, 1982). Just as DA can
be generated via AADC in endothelia subsequent to hypoxic stress
(Pfeil et al., 2014), intracellularly-synthesized TAs may comprise
an integral physiological component of the autonomic stress
response.
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